Sanofi Stock Quote SAN - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

91.23

Bid

91.00

Ask

91.62

Volume

1,682,358

89.63 Day's Range 91.72

80.60 52 Week Range 105.18

Market Cap

115.388B

Previous Close

91.62

Open

91.38

Last Trade

91.23

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,378,674

Shares Outstanding

1,264,803,301

Dividend Yield

7.80%

PE Ratio

21.37

Earnings Per Share (EPS)

4.27

Revenue

43.07B

Net Profit

5.4B

Sector

Health & Allied Services,nec

Industry

Pharmaceutical Preparations

Website

www.sanofi.com

Headquarters

Paris, Paris, Fra

Founded

1994

Sanofi is listed in the Health & Allied Services sector of the Euronext with ticker SAN. The last closing price for Sanofi was 91.62 €. Over the last year, Sanofi shares have traded in a share price range of 80.60 € to 105.18 €.

Sanofi currently has 1,264,803,301 shares outstanding. The market capitalization of Sanofi is 115.39 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.37.

Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancements

Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancements ...

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris...

Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia

Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia Pivotal data from the first phase 3 study of a BTKi in immune thrombocytopenia (ITP) underscore the potential of...

Communiqué de presse : De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en plaques

Communiqué de presse : De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	5.96	6.98956256597	85.27	92.56	85.07	1868628	89.15905962	DE
4	1.86	2.08123531386	89.37	92.56	85.07	1455399	87.92972975	DE
12	2.13	2.39057239057	89.1	92.56	84.93	1378674	87.94406219	DE
26	-9.35	-9.29608272022	100.58	101.12	80.6	1534020	87.96721227	DE
52	-12.89	-12.3799462159	104.12	105.18	80.6	1451581	93.0829967	DE
156	5.72	6.68927610806	85.51	106.66	76.45	1799798	91.13322069	DE
260	15.73	20.8344370861	75.5	106.66	67.65	2055259	87.28620429	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M